Business context and reporting period
Period: Quarter ended March 31, 2015. The supplied filing identifies the registrant as SMSA Ballinger Acquisition Corp., not REALLOYS INC.; verify the company identity before relying on this summary.
The company reported no operating revenue or assets other than $119 cash and described itself as a shell/development-stage company. Its plan was to market healthcare consumer products, including nasal aspirators, in Brazil and Chile under an exclusive South American distributor agreement. The agreement was set to expire May 15, 2015, with a possible two-year extension by mutual written consent.
Financial performance and position
- Revenue: $0 in Q1 2015 and Q1 2014.
- Net loss: $13,575 in Q1 2015 versus $5,767 in Q1 2014. Loss per share was reported as $(0.00) in both periods.
- Expenses: Total expenses were $13,575 versus $5,767; professional fees rose to $13,575 from $5,000. The filing attributes costs to maintaining the corporate entity.
- Cash flow: Operating cash use was $1,500 versus $8,767 in Q1 2014. A $1,500 contribution from related parties funded the 2015 operating cash use; ending cash remained $119. No investing cash flows or interest and income taxes paid were reported.
- Balance sheet at March 31, 2015: Cash and total assets were $119; accounts payable and accrued expenses and total liabilities were $13,575; stockholders’ deficit was $13,456. No debt is separately reported.
- Comparative balance sheet: At December 31, 2014, cash was $119, accounts payable were $1,500, and stockholders’ deficit was $1,381. The filing states working capital of approximately negative $13,500 at March 31, 2015, versus negative $1,400 at March 31, 2014.
- Margins: Not meaningful because the company had no revenue.
Changes, outlook, and risks
- Quarterly loss increased by $7,808 year over year, while operating cash use decreased. The company had no revenue in either period.
- Management estimated a need for up to $50,000 over the next 12 months for working capital, reporting costs, and initial market research. It said the majority stockholder might provide this funding, but there was no formal commitment or legal obligation.
- Management estimated at least $500,000 would be needed to establish a viable distribution system, contingent on favorable market indications. The company aimed to complete this financing by August 31, 2015 and implement distribution by December 31, 2015. Neither funding nor successful implementation was assured.
- Management expected initial market research in Brazil and Chile to be completed by the end of Q2 2015. The company had no arrangements with sales or distribution firms, or with manufacturers, for its products.
- The auditors’ 2014 opinion included substantial doubt about the company’s ability to continue as a going concern. The company depended on external financing and could become dormant if funding was unavailable.
- Management said a future securities offering could substantially dilute existing shareholders; preferred shares could have rights senior to common stock.
- Disclosure controls were judged ineffective due to an internal-control weakness associated with shell-company status and having one officer and director. No significant control changes were reported during the quarter.
- The sole officer and director, Orsolya Peresztegi, was responsible for day-to-day operations and was not bound by a written employment or consulting agreement. HFG Consulting, an affiliate of shareholders, provided marketing assistance for no consideration; related parties contributed approximately $1,500 in Q1 2015.
Important facts to verify
- Confirm the filing belongs to the intended issuer: the document names SMSA Ballinger Acquisition Corp., not REALLOYS INC.
- Verify whether the distributor agreement was extended beyond May 15, 2015 and whether the company completed its market research.
- Check whether the anticipated $50,000 working-capital support and $500,000 financing were obtained, and on what terms.
- Review subsequent filings for changes in cash, accrued liabilities, going-concern disclosures, ownership, and potential dilution.
- Assess remediation of ineffective disclosure controls and the company’s reliance on a sole officer and director.